Skip to content
healthcare.dev

HYDRALAZINE HYDROCHLORIDE

NDC 43066-041, HYDRALAZINE HYDROCHLORIDE, injection, from Baxter Healthcare Corporation.

Product NDC
43066-041
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219797
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43066-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
43066-041-254306600412525 VIAL, SINGLE-DOSE in 1 CARTON (43066-041-25) / 1 mL in 1 VIAL, SINGLE-DOSE (43066-041-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f1a10203-f027-4f9c-8dd6-907c6db24d47
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=43066-041

Use it

Look up 43066-041 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43066-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43066-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.